A ruthenium(II) complex bearing a naphthyridine-functionalized pyrazole ligand catalyzes oxidant-free and acceptorless selective double dehydrogenation of primary amines to nitriles at moderate temperature. The role of the proton-responsive entity on the ligand scaffold is demonstrated by control experiments, including the use of a N-methylated pyrazole analogue. DFT calculations reveal intricate hydride and proton transfers to achieve the overall elimination of 2 equiv of H.
A bromo-capped metal-metal bonded diruthenium(i,i) complex Ru2(CO)4(PIN)2Br2 (1) (PIN = 1-isopropyl-3-(5,7-dimethyl-1,8-naphthyrid-2-yl)imidazol-2-ylidene) generates bromine with N-bromosuccinimide (NBS) at room temperature. Cycloalkene and stilbene are readily brominated by stoichiometric reactions with 1 and NBS. An analysis of the dibrominated products suggests the formation of cyclic bromonium intermediates indicating in situ Br2 generation. Complex 2, an iodide analogue of 1, is also synthesized. The reaction of 2 with N-iodosuccinimide releases I2, which is confirmed by the starch-iodine test. The catalytic utility of 1 is examined for the bromination of phenol. Catalyst 1, in combination with NBS and base, exhibits regioselectivity towards monobrominated products. Furthermore, efficient olefin aziridination is demonstrated utilizing catalyst 1 in the presence of NBS, K2CO3 and TsNH2.
PurposeThe purpose of this paper is to examine the impact on selected financial performance indicators of Indian firms adopting employee stock option (ESO) schemes, if they recognize expenses and adopting fair‐value method of accounting pursuant to International Financial Reporting Standard (IFRS) 2.Design/methodology/approachThe CMIE Prowess database was searched for Indian firms having stock option schemes and issue of shares pursuant to that scheme during the years ended 31 March 2007 and 31 March 2008. The data on financial performance were hand picked from the annual report of the sample companies. The impact of expense recognition on financial performance indicators were computed by using memorandum disclosures in directors' reports on use of fair value methods for ESO accounting. A non‐parametric Kruskal‐Wallis test was employed to find out the statistical significance of the impact. The role of firm growth characteristics on impact of expense recognition was also investigated.FindingsThe impact of recognizing expenses associated with stock option compensation varies considerably by entity and such recognition would have a material impact on key performance measure for at least 22 percent of the sample companies. Contrary to expectation, firm growth characteristics were found to have no statistical significance in explaining impact of expense recognition.Research limitations/implicationsThe sample is restricted to India and may not be reflective of other countries. Also, this study considers the impact of expense recognition as if the requirements of IFRS 2 were adopted in 2006‐2007/2007‐2008 financial year and accordingly, may not be reflective of the situation that may prevail in 2011 when transition to IFRS set of standards will be applicable to Indian companies, as those entities may have altered their compensation contracts.Practical implicationsIndian firms will be required to prepare financial statements based on IFRS set of standards w.e.f. April 2011. IFRS 2, share‐based payments is not yet adopted in India. Overall, the significance of accounting changes associated with the adoption of IFRS 2 may not be very alarming for Indian companies with ESO schemes.Originality/valueThis study attempts to enrich empirical research in the field and provides an insight into the potential contractual and valuation implication of the adoption of one of the IFRS set of standards on Indian firms and also provides contrary evidence of the role of growth characteristics in explaining the impact of expense recognition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.